Clinical Trial Manager II, Early Phase and Translational Research (CTM II, EPTR), Canada - North America
The Clinical Trial Manager II, Early Phase and Translational Research (CTM II, EPTR) is responsible for the operational management and oversight of the clinical investigative sites as well as the clinical monitoring deliverables of Early Phase clinical trials. This includes but is not limited to clinical research associate (CRA) training, identification of quality issues related to site performance and clinical monitoring activities, establishing action plans to address any concerns, as well as ensuring timelines are met. The CTM II, EPTR may also perform project management responsibilities on select trials with limited Sponsor involvement (eg, observational, IIS, etc).
This role will be perfect for you if:
RESPONSIBILITIES
The Clinical Trial Manager II, Early Phase and Translational Research:
The CTM II, EPTR may also assume the following responsibilities of primary contact for Sponsor on select studies (eg, observational, IIS):
IDEAL PROFILE
Education
Experience
Knowledge and skills
The work environment
At Innovaderm, you will work with brilliant and driven colleagues. Our values are collaboration, innovation, reliability and responsiveness. We offer a stimulating work environment and attractive advancement opportunities.
As a Clinical Trial Manager II, Early Phase and Translational Research, you will be eligible for the following perks:
About Innovaderm
Innovaderm is a contract research organization (CRO) specialized in dermatology with a team of over 175 employees. Since its beginnings in 2000, our organization has benefited from a solid reputation for the quality of its research and services exceeding the expectations of its clients. Based in Montreal, Innovaderm continues to grow and expand in North America.
Innovaderm is committed to providing equitable treatment and equal opportunity to all individuals. As such, Innovaderm will provide accommodations throughout the recruitment and selection process to applicants with disabilities, upon request.
We thank you for your application and please note that only those selected for an interview will be contacted.